Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
17153 | 551 | 45.9 | 95% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | IL 27 | Author keyword | 86 | 64% | 15% | 83 |
2 | INTERLEUKIN 27 | Author keyword | 72 | 70% | 11% | 60 |
3 | IL 35 | Author keyword | 27 | 66% | 5% | 25 |
4 | EBI3 | Author keyword | 23 | 100% | 2% | 10 |
5 | EPSTEIN BARR VIRUS INDUCED GENE 3 | Author keyword | 17 | 100% | 1% | 8 |
6 | INTERLEUKIN 35 | Author keyword | 14 | 64% | 3% | 14 |
7 | WSX 1 | Author keyword | 9 | 83% | 1% | 5 |
8 | INTRACTABLE IMMUNE SYST DIS | Address | 6 | 34% | 3% | 15 |
9 | IL 27P28 | Author keyword | 4 | 75% | 1% | 3 |
10 | MOL CELLULAR IMMUNOSCI | Address | 4 | 33% | 2% | 10 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IL 27 | 86 | 64% | 15% | 83 | Search IL+27 | Search IL+27 |
2 | INTERLEUKIN 27 | 72 | 70% | 11% | 60 | Search INTERLEUKIN+27 | Search INTERLEUKIN+27 |
3 | IL 35 | 27 | 66% | 5% | 25 | Search IL+35 | Search IL+35 |
4 | EBI3 | 23 | 100% | 2% | 10 | Search EBI3 | Search EBI3 |
5 | EPSTEIN BARR VIRUS INDUCED GENE 3 | 17 | 100% | 1% | 8 | Search EPSTEIN+BARR+VIRUS+INDUCED+GENE+3 | Search EPSTEIN+BARR+VIRUS+INDUCED+GENE+3 |
6 | INTERLEUKIN 35 | 14 | 64% | 3% | 14 | Search INTERLEUKIN+35 | Search INTERLEUKIN+35 |
7 | WSX 1 | 9 | 83% | 1% | 5 | Search WSX+1 | Search WSX+1 |
8 | IL 27P28 | 4 | 75% | 1% | 3 | Search IL+27P28 | Search IL+27P28 |
9 | IL 30 | 2 | 67% | 0% | 2 | Search IL+30 | Search IL+30 |
10 | ITR35 | 2 | 67% | 0% | 2 | Search ITR35 | Search ITR35 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IL 27 | 174 | 74% | 24% | 130 |
2 | INTERLEUKIN 27 | 147 | 79% | 17% | 94 |
3 | WSX 1 | 73 | 85% | 7% | 39 |
4 | INDUCED GENE 3 | 60 | 100% | 4% | 20 |
5 | I CYTOKINE RECEPTOR | 42 | 71% | 6% | 34 |
6 | TH1 DIFFERENTIATION | 40 | 61% | 8% | 43 |
7 | VIRUS INDUCED GENE 3 | 37 | 100% | 3% | 14 |
8 | IL 27 RECEPTOR | 21 | 90% | 2% | 9 |
9 | IL 27 RECEPTOR WSX 1 | 21 | 85% | 2% | 11 |
10 | CHAIN WSX 1 | 20 | 100% | 2% | 9 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
IL-12 family cytokines: immunological playmakers | 2012 | 154 | 93 | 45% |
The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy | 2015 | 1 | 94 | 52% |
Interleukin-27: Balancing Protective and Pathological Immunity | 2012 | 48 | 110 | 74% |
New directions in the basic and translational biology of interleukin-27 | 2012 | 51 | 107 | 66% |
IL-27 in tumor immunity and immunotherapy | 2013 | 19 | 92 | 57% |
Modulation of inflammation by interleukin-27 | 2013 | 10 | 72 | 79% |
Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease | 2015 | 1 | 62 | 37% |
Interleukin 27: a double-edged sword for offense and defense | 2009 | 63 | 92 | 78% |
Advances in understanding the anti-inflammatory properties of IL-27 | 2008 | 84 | 86 | 71% |
Discovery and biology of IL-23 and IL-27: Related but functionally distinct regulators of inflammation | 2007 | 379 | 84 | 46% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTRACTABLE IMMUNE SYST DIS | 6 | 34% | 2.7% | 15 |
2 | MOL CELLULAR IMMUNOSCI | 4 | 33% | 1.8% | 10 |
3 | CE SI AGING | 3 | 57% | 0.7% | 4 |
4 | INFECT DISMINIST EDUC | 2 | 67% | 0.4% | 2 |
5 | TUMORIGENESIS IMMUN | 2 | 67% | 0.4% | 2 |
6 | AIRC IMMUNOL TUMORS | 1 | 31% | 0.7% | 4 |
7 | ADV TECHNOL PROGRAM DIRECTORATE | 1 | 50% | 0.4% | 2 |
8 | FEDERAT RECH NECKER | 1 | 100% | 0.4% | 2 |
9 | VIRAL HEPATITIS MOL BIOL INFECT DIS | 1 | 33% | 0.4% | 2 |
10 | ASSOC ITALIANA RIC CANC | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000155825 | IL 17//INTERLEUKIN 17//TH17 |
2 | 0.0000137731 | INTERLEUKIN 12//IL 12//IL 12 RECEPTOR |
3 | 0.0000082802 | T BET//GATA 3//HELPER T CELL DIFFERENTIATION |
4 | 0.0000066321 | INTERLEUKIN 32//IL 32//CYTOKINE IMMUNOL |
5 | 0.0000064712 | CDK2AP1//DOC 1//P12CDK2 AP1 |
6 | 0.0000063767 | IL 37//TIR8//INTERLEUKIN 37 |
7 | 0.0000060498 | INTERLEUKIN 21//IL 21//FOLLICULAR HELPER T CELLS |
8 | 0.0000060490 | CHEMOKINE LIKE FACTOR 1//CKLF1//CMTM5 |
9 | 0.0000057655 | FOXP3//REGULATORY T CELLS//REGULATORY T CELL |
10 | 0.0000054955 | RHEUMATOL CONNECT TISSUE//COMMON RECEPTOR CHAIN//HLTH SCI B115 |